Actively Recruiting
Sarcopenia in Older Patients in the Acute Hospital Setting
Led by Rambam Health Care Campus · Updated on 2024-05-07
50
Participants Needed
1
Research Sites
219 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study will assess whether the use of technology using the Virtual Gate Device (VGD) will prevent or minimize the development of hospital acquired Sarcopenia resulting from Immobilization.
CONDITIONS
Official Title
Sarcopenia in Older Patients in the Acute Hospital Setting
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male and female patients 75 years of age and older.
- Patients admitted with an acute infection clinically from a respiratory or urinary source.
- Expected length of hospitalization of at least 4 days.
- Patients who are conscious and cognitively able to provide written informed consent as determined by a score of 0 on the 4AT scale
You will not qualify if you...
- Male and female patients under 75 years of age.
- Expected length of hospitalization of less than 4 days.
- Conditions limiting the use of the Virtual Gait Device (VGD) including fracture, amputation, local infection, pain, paralysis of one or both lower limbs, cardiac arrhythmia, or cardiac pacemaker.
- Patients unable or unwilling to provide informed consent.
- A score of 1 or more on the 4AT scale.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Rambam Health Care Campus
Haifa, North, Israel, 3109601
Actively Recruiting
Research Team
T
Tzvi Dwolatzky, MD
CONTACT
E
Elad Rubin
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
PREVENTION
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here